Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology
- PMID: 25641009
- DOI: 10.1016/j.ejrad.2015.01.002
Diffusion-weighted imaging and dynamic contrast-enhanced MRI of experimental breast cancer bone metastases--a correlation study with histology
Abstract
Purpose: To validate imaging parameters from diffusion-weighted imaging and dynamic contrast-enhanced MRI with immunohistology and to non-invasively assess microstructure of experimental breast cancer bone metastases.
Materials and methods: Animals bearing breast cancer bone metastases were imaged in a clinical 1.5 T MRI scanner. HASTE sequences were performed to calculate apparent diffusion coefficients. Saturation recovery turbo FLASH sequences were conducted while infusing 0.1 mmol/l Gd-DTPA for dynamic contrast-enhanced MRI to quantify parameters amplitude A and exchange rate constant kep. After imaging, bone metastases were analyzed immunohistologically.
Results: We found correlations of the apparent diffusion coefficients from diffusion-weighted imaging with tumor cellularity as assessed with cell nuclei staining. Histological vessel maturity was correlated negatively with parameters A and kep from dynamic contrast-enhanced MRI. Tumor size correlated inversely with cell density and vessel permeability as well as positively with mean vessel calibers. Parameters from the rim of bone metastases differed significantly from values of the center.
Conclusion: In vivo diffusion-weighted imaging and dynamic contrast-enhanced MRI in experimental bone metastases provide information about tumor cellularity and vascularity and correlate well with immunohistology.
Keywords: Angiogenesis; Bone metastases; Breast cancer model; Brix model; Diffusion-weighted magnetic resonance imaging; Dynamic contrast-enhanced magnetic resonance imaging.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
Quantitative contrast-enhanced ultrasound for imaging antiangiogenic treatment response in experimental osteolytic breast cancer bone metastases.Invest Radiol. 2012 Jul;47(7):422-9. doi: 10.1097/RLI.0b013e31824f635a. Invest Radiol. 2012. PMID: 22659593
-
Use of diffusion-weighted, intravoxel incoherent motion, and dynamic contrast-enhanced MR imaging in the assessment of response to radiotherapy of lytic bone metastases from breast cancer.Acad Radiol. 2014 Oct;21(10):1286-93. doi: 10.1016/j.acra.2014.05.021. Epub 2014 Aug 1. Acad Radiol. 2014. PMID: 25088834 Clinical Trial.
-
Drug-induced vessel remodeling in bone metastases as assessed by dynamic contrast enhanced magnetic resonance imaging and vessel size imaging: a longitudinal in vivo study.Clin Cancer Res. 2010 Jun 15;16(12):3215-25. doi: 10.1158/1078-0432.CCR-09-2932. Epub 2010 Jun 8. Clin Cancer Res. 2010. PMID: 20530698
-
Review of diffusion-weighted imaging and dynamic contrast-enhanced MRI for multiple myeloma and its precursors (monoclonal gammopathy of undetermined significance and smouldering myeloma).Skeletal Radiol. 2022 Jan;51(1):101-122. doi: 10.1007/s00256-021-03903-8. Epub 2021 Sep 14. Skeletal Radiol. 2022. PMID: 34523007 Review.
-
Interpretation of breast MRI: correlation of kinetic and morphological parameters with pathological findings.Magn Reson Med Sci. 2004;3(4):189-97. doi: 10.2463/mrms.3.189. Magn Reson Med Sci. 2004. PMID: 16093637 Review.
Cited by
-
PET/MR Imaging of Somatostatin Receptor Expression and Tumor Vascularity in Meningioma: Implications for Pathophysiology and Tumor Outcomes.Front Oncol. 2022 Jan 28;11:820287. doi: 10.3389/fonc.2021.820287. eCollection 2021. Front Oncol. 2022. PMID: 35155210 Free PMC article.
-
Prediction of therapy response in bone-predominant metastatic breast cancer: comparison of [18F] fluorodeoxyglucose and [18F]-fluoride PET/CT with whole-body MRI with diffusion-weighted imaging.Eur J Nucl Med Mol Imaging. 2019 Apr;46(4):821-830. doi: 10.1007/s00259-018-4223-9. Epub 2018 Dec 1. Eur J Nucl Med Mol Imaging. 2019. PMID: 30506455 Free PMC article. Clinical Trial.
-
Bone Metastases Are Measurable: The Role of Whole-Body MRI and Positron Emission Tomography.Front Oncol. 2021 Nov 19;11:772530. doi: 10.3389/fonc.2021.772530. eCollection 2021. Front Oncol. 2021. PMID: 34869009 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical